SEC Filing Update: #QNCX Quince Therapeutics, Inc. : $34.04

Sector: Healthcare | YTD: πŸ”½ -94.33% The SEC disclosed Today (14-AUG-2026) that NANTAHALA CAPITAL MANAGEMENT, L has DECREASED #QNCX Shares by -100.00% πŸ”΄ BALYASNY ASSET MANAGEMENT LLC also reported an increase in its holdings on the same day. CORMORANT ASSET MANAGEMENT, LP also reported an increase in its holdings on the same day. * Previous Holdings: 4.53M Shares * Current Holdings: 0.00 Shares * Decrease -4.53M * Decreased (%)-100.00% * Ownership: 0.0% https://www.thinksabio.com/reports/isr/QNCX πŸ“Œ Institutional activity in the last 30 days for #QNCX: β€’ BALYASNY ASSET MANAGEMENT LLC – Increased holdings by 27,732 shares (14-AUG-2026) β€’ CORMORANT ASSET MANAGEMENT, LP – Increased holdings by 102,531 shares (14-AUG-2026)